Today: 21 May 2026
Browse Category

NYSE:UNH 30 November 2025 - 16 December 2025

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth (UNH) closed Monday down 0.22% at $341.10 and slipped to $340.14 after hours. The move followed Fitch’s downgrade of rival Humana, citing higher medical costs and weaker Medicare Advantage bonuses. UNH traded 6.3 million shares in a $337–$344.96 range. Industry commentary remains focused on rising expenses and regulatory pressure.
16 December 2025
···
UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth Group (UNH) Stock News Today: December 15, 2025 Headlines, Analyst Forecasts, and What Investors Are Watching Next

UnitedHealth shares fell 1.27% to $337.51 as of 15:27 UTC Monday, trading in a narrow range amid legal headlines and sector rotation. The company will report full-year 2025 results and issue 2026 guidance before the market opens on January 27. A $2.21 quarterly dividend is set for payment December 16. Trading volume reached about 1.75 million shares.
15 December 2025
·
UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

UnitedHealth Group (UNH) Stock News and Forecasts on Dec. 14, 2025: DOJ-Amedisys Deal, Optum Opioid Lawsuit, Earnings Date, and Analyst Targets

A federal court approved a DOJ settlement in UnitedHealth’s Amedisys merger case, requiring divestitures and a $1.1 million penalty. West Virginia filed suit against Optum over opioid sales allegations. UnitedHealth shares closed Friday at $341.84, up 1.5%. The company will report full-year 2025 earnings and 2026 guidance on Jan. 27.
14 December 2025
··
UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group (UNH) Stock This Week: DOJ-Amedisys Final Judgment, Fresh Legal Risks, Analyst Forecasts, and What to Watch Next Week (Updated Dec. 12, 2025)

UnitedHealth Group shares closed Friday, Dec. 12, 2025, at $341.84, up 1.52%, capping a 5.6% weekly gain despite a broader market decline. The week included a federal court approving UnitedHealth’s $3.3 billion Amedisys acquisition with required divestitures, and a new opioid-related lawsuit filed by West Virginia against Optum.
13 December 2025
·
UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth (UNH) Stock After Hours on Dec. 12, 2025: Earnings Date Set, Policy Catalysts, and What to Watch Next

UnitedHealth shares closed Friday at $341.84, up 1.52%, defying a broader market decline. After-hours trading saw the stock dip to around $341.33. The company announced it will report full-year 2025 results and 2026 guidance on January 27, 2026. Managed-care stocks, including UNH, gained Friday amid renewed efforts in Congress to extend ACA subsidies.
12 December 2025
··
UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth Group (UNH) Stock News Today: DOJ Amedisys Ruling, Optum Lawsuit Risks, and Analyst Forecasts (Dec. 12, 2025)

UnitedHealth shares closed at $336.73 on Dec. 11 and traded near $337.95 pre-market Friday, approaching a key technical level. A federal court approved the DOJ settlement for UnitedHealth’s $3.3 billion Amedisys acquisition, requiring divestiture of 164 home health and hospice sites. The stock’s 52-week range is $234.60 to $606.36. UnitedHealth and Optum also face a West Virginia lawsuit over alleged opioid oversupply.
12 December 2025
UnitedHealth Group (UNH) Stock After the Bell on Dec. 11, 2025 – And What to Watch Before the Dec. 12 Open

UnitedHealth Group (UNH) Stock After the Bell on Dec. 11, 2025 – And What to Watch Before the Dec. 12 Open

UnitedHealth Group shares closed Thursday at $336.50, up about 2.5% on volume near 7 million, as the Dow hit a record high. After-hours trading was quiet, with the stock near $336.70. UNH’s market cap stands at roughly $305 billion, still well below its 2025 peak near $600. Options activity surged, with contracts traded at about double the average share volume.
12 December 2025
··
US Stock Market Today: Dow Rockets to Record Above 48,700 as S&P 500 Hits New High, Nasdaq Slips on Oracle AI Jitters

US Stock Market Today: Dow Rockets to Record Above 48,700 as S&P 500 Hits New High, Nasdaq Slips on Oracle AI Jitters

The Dow Jones closed at a record 48,704, up 1.3%, while the S&P 500 also hit a new high at 6,900.99. The Nasdaq fell 0.25% to 23,594 as tech and AI stocks slid after Oracle shares dropped 11–13% on heavy AI spending and negative free cash flow. Three-quarters of S&P 500 stocks rose. The day followed a Fed rate cut and a spike in jobless claims.
11 December 2025
······
UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth Group (UNH) Stock Outlook After the November 21 Rebound: Can the Healthcare Giant Regain Its Swagger in 2026?

UnitedHealth shares climbed to $332–334 intraday on December 11, up from $319.97 on November 21, but remain down about 35% over the past year. The stock trades at a trailing P/E of 14.9×, below sector average, but a forward P/E of 19×, slightly above peers. Dividend yield stands at 2.8%, with the next payout set for December 16. DOJ probe and Medicare Advantage reset continue to weigh on outlook.
11 December 2025
·
UnitedHealth Group (UNH) Stock Forecast 2026: Can the Healthcare Giant Recover From 2025’s Crises?

UnitedHealth Group (UNH) Stock Forecast 2026: Can the Healthcare Giant Recover From 2025’s Crises?

UnitedHealth Group shares closed at about $324 on December 10, 2025, down roughly 39% over the past year. The company faced a series of shocks, including the December 2024 assassination of UnitedHealthcare’s CEO and a DOJ criminal probe into Medicare Advantage billing. Revenue rose 11–12% year over year to $334.4 billion for the first nine months of 2025.
10 December 2025
··
UnitedHealth Group (UNH) Stock Today: Price, West Virginia Opioid Lawsuit, Guidance Raise and 2026 Forecasts

UnitedHealth Group (UNH) Stock Today: Price, West Virginia Opioid Lawsuit, Guidance Raise and 2026 Forecasts

UnitedHealth Group shares traded near $324 Tuesday afternoon, little changed despite a new opioid lawsuit from West Virginia and ongoing DOJ probes. The stock is up about 35% year-to-date, far outpacing the S&P 500. Management raised 2025 earnings guidance last week. Wall Street targets imply nearly 20% upside, though short-term trading models flag weakness.
9 December 2025
··
UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group (UNH) Stock: 2026 Comeback Hopes After a Brutal 2025 – What Investors Need to Know Today (December 8, 2025)

UnitedHealth Group shares traded near $325 on December 8, 2025, down about 34% year-to-date after surging medical costs, a major cyberattack, and DOJ investigations. The company raised 2025 EPS guidance to at least $14.90 GAAP and $16.25 adjusted. UNH went ex-dividend today for a $2.21 quarterly payout, yielding 2.7%. Analyst targets imply mid-teens upside from current levels.
8 December 2025
·
UNH Stock Outlook on December 6, 2025: Can UnitedHealth’s Turnaround Power a 2026 Rebound?

UNH Stock Outlook on December 6, 2025: Can UnitedHealth’s Turnaround Power a 2026 Rebound?

UnitedHealth Group shares closed at $330.91 on December 6, down about a third in 2025 and more than 40% below their late-2024 peak. The stock swung sharply this week, driving a 400-point Dow rally on December 3 and a 150-point drop the next day. Hedge fund Epoch Investment Partners cut its stake by 82% in Q2. UnitedHealth’s medical cost ratio surged to nearly 90% in 2025, forcing a major earnings guidance cut.
6 December 2025
·
UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth shares traded at $332–$334 on December 5, 2025, rebounding from May lows in the $230s after a year marked by a DOJ probe and a major data breach. The stock remains about 45% below its December 2024 high near $610. Analysts estimate 2025 EPS at $16.29, down 41% from the prior year. Simply Wall St values UNH at $847 per share, suggesting a 60% discount to intrinsic value.
5 December 2025
··
UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group (UNH) Stock Today: Latest News, Analyst Forecasts and 2026 Outlook as of December 4, 2025

UnitedHealth Group shares traded around $333–340 on December 4, 2025, down over 45% from last year’s high after a year marked by a cyberattack, DOJ investigations, and the killing of a top executive. Stephen Hemsley returned as CEO amid the turmoil. Despite the rebound from lows, the stock remains about 25–30% lower year-to-date, underperforming the S&P 500.
4 December 2025
·
UnitedHealth Group (UNH) Stock Surges as Wall Street Backs 2026 Turnaround – Price, Outlook and Key Risks

UnitedHealth Group (UNH) Stock Surges as Wall Street Backs 2026 Turnaround – Price, Outlook and Key Risks

UnitedHealth closed at $339.71 on December 3, up 4.7% after management raised guidance and analysts upgraded price targets. The stock has rebounded about 45% from its lows but remains 45% below its 52-week high. The board approved a $2.21 quarterly dividend, payable December 16. Wolfe Research lifted its price target to $375, citing margin recovery and earnings growth.
4 December 2025
·
UnitedHealth Group (UNH) Stock Today: Price, Forecast and 2026 Recovery Prospects (December 2, 2025)

UnitedHealth Group (UNH) Stock Today: Price, Forecast and 2026 Recovery Prospects (December 2, 2025)

UnitedHealth traded at $325–326 on December 2, 2025, up slightly from Monday’s close of $323.21 but down nearly 50% from late 2024 highs. The stock remains far below its 52-week peak after regulatory scrutiny, a major cyberattack, and operational missteps. Analysts maintain a “Buy” rating, with a consensus price target near $397. Recent research highlights both deep-value potential and ongoing risks.
2 December 2025
·
UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth Group (UNH) Stock Outlook Before December 1, 2025: Can Bulls Look Past DOJ Risk and Medicare Pressures?

UnitedHealth closed Friday at $329.77, down 47% from its 52-week high and about 34–35% lower year to date. The stock remains roughly 40% above its recent low, with after-hours trading at $329.50. Regulatory probes and lawsuits continue to weigh on sentiment despite a Q3 earnings beat and a 2.7% forward dividend yield. Institutional holders control about 88% of shares, with recent filings showing mixed activity.
30 November 2025
1 … 6 7 8 9 10

Stock Market Today

  • Planet Labs Nears Sustainable Profitability Amid Industry Challenges
    May 21, 2026, 3:12 PM EDT. Planet Labs (PL) operates a vast network of Earth observation satellites capturing global images daily. Despite technological advances and expanded roles in defense and agriculture, the company has yet to secure steady profits due to high costs in satellite manufacturing, launches, maintenance, and R&D. Revenue growth lags behind fixed costs, while long government sales cycles delay cash flow. Management's 2026 guidance shows optimism, focusing on cost control, vertical specialization, and software monetization to enhance margins. Industry peers Rocket Lab (RKLB) and BlackSky Technology (BKSY) face similar profitability challenges. PL's stock has surged 117% year-to-date but trades at a lofty price-to-sales ratio of 31.38, far above the industry average of 3.86, reflecting high investor expectations amid ongoing financial pressures.

Latest articles

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

Nebius Shares Surge 15% After $2.6 Billion AI Power Plan Announced

21 May 2026
Nebius Group N.V. shares surged 15.6% to $221.72 after announcing a fuel cell power deal with Bloom Energy, securing up to 328 MW of on-site electricity capacity for its AI infrastructure. The agreement could cost Nebius up to $2.6 billion over 10 years. Bloom shares rose 12.2% on the news. Nebius's first-quarter revenue jumped to $399 million from $50.9 million a year earlier.
Sirius XM stock nears new highs as traders look at audio strategy

Sirius XM stock nears new highs as traders look at audio strategy

21 May 2026
Sirius XM shares rose 6.8% to $28.90 by 2:07 p.m. EDT Thursday, outpacing major U.S. indexes. The rally followed CFO Zac Coughlin’s investor conference appearance and news of a renewed multi-year NASCAR broadcast deal. First-quarter subscriber losses were smaller than expected, and revenue topped forecasts. Volume reached 4.8 million shares, with a market value near $9.8 billion.
KEEL Surges as Investors Back Keel’s AI Data Center Plans

KEEL Surges as Investors Back Keel’s AI Data Center Plans

21 May 2026
Keel Infrastructure shares jumped 7.1% to $4.53 Thursday, nearing a 52-week high, as investors bet on its pivot from crypto mining to AI-focused power infrastructure. Trading volume reached 22.31 million shares, below average. The company reported a wider net loss of $145.35 million for the March quarter on lower revenue and warned its transformation faces risks tied to permits, costs, and competition.
Go toTop